David Latini|Eric P. Elkin|Matthew R. Cooperberg|Natalia Sadetsky|Janeen DuChane|Peter R. Carroll
Differences in clinical characteristics and disease?free survival for Latino, African American, and non?Latino white men with localized prostate cancer
UCSF Helen Diller Family Comprehensive Cancer Center|University of California, San Francisco|UCSF Helen Diller Family Comprehensive Cancer Center|University of California, San Francisco|UCSF Helen Diller Family Comprehensive Cancer Center|University of California, San Francisco|UCSF Helen Diller Family Comprehensive Cancer Center|University of California, San Francisco|UCSF Helen Diller Family Comprehensive Cancer Center|University of California, San Francisco
studies ethnicity prostate cancer included latino men analyses baseline clinical characteristics treatment selection diseasefree survival dfs present study examines impact latino ethnicity parameters large multiinstitutional database men prostate cancerwe compared baseline disease characteristics clinical outcomes latino n 138 nonlatino white nlw n 5619 africanamerican aa n 608 men localized prostate cancer using chisquare anova baseline variables survival analysis examine differences time recurrencelatino men resembled aa men nlw sociodemographic characteristics aa men higher gleason scores prostatespecific antigen psa diagnosis latino nlw men p 001 10 latino aa men presented advanced disease t3bt4nm versus 4 nlw p 001 latino men receive different treatments nlw aa men controlling clinical demographic factors however aa men likely receive external beam radiation 151 95 confidence interval ci 099231 hormone treatment 156 95 ci 105232 nlw men prostatectomy patients 3year actuarial dfs rates 83 nlw men 86 latino men versus 69 aa men p 001 controlling clinical sociodemographic variables aa men somewhat likely nlw experience disease recurrence radical prostatectomy rp hr 138 95 ci 098194 p 006latinos similar african americans sociodemographic characteristics similar nlw clinical presentation treatments received dfs